Addex Therapeutics Ltd
ADXN | NASDAQ
$3.53
+$0.13 (+3.98%)
At close: Sep 21, 2026, 4:00 PM ET
$3.32
-$0.21 (-5.95%)
Pre-market:
Sep 22, 2026, 4:31 AM ET
Fiscal Quarter Period Ending | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.71M | -1.82M | -1.58M | -1.84M | -1.47M | -1.21M | -1.53M | 12.88M | -3.09M | -2.86M | -2.62M | -2.68M | -2.41M | -3.65M | -4.11M | -7.22M | -5.82M | -4.42M | -3.6M | -4.69M | -2.64M |
Depreciation & Amortization | 9.82K | 2.1K | 2.12K | 2.12K | 2.12K | 23.8K | 53.58K | 112.38K | 2.94K | 79.39K | 75.38K | 75.41K | 75.78K | 75.65K | 77.32K | 83.35K | 86.83K | 82.97K | 87.74K | 88.26K | 88.65K |
Stock-Based Compensation | 22.91K | n/a | n/a | n/a | 24.92K | n/a | 38.45K | 47.23K | 386.03K | 389.21K | 483.46K | 490.6K | 431.2K | 684.77K | 898K | 659.26K | 1.44M | 274.33K | 381.07K | 336.85K | 186.1K |
Other Working Capital | -201.07K | 101.15K | 156.22K | 270.69K | -150.96K | -62.63K | 79.7K | -1.89M | -294.53K | 1.51M | -222.49K | -752.85K | -625.89K | -243.92K | 517.69K | 551.18K | -484.94K | 897.91K | 578.81K | -1.44M | 395.88K |
Other Non-Cash Items | 1.13M | 1.06M | 898.5K | 1.15M | 1.02M | 720.01K | 859.74K | -13.43M | -57.79K | 572.05K | -37.53K | 138.56K | -19.82K | 204.57K | -109.94K | 62.13K | 47.37K | 201.16K | 45.33K | 293.1K | -684.56K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -389.21K | -5.27K | -9.15K | n/a | n/a | n/a | n/a | n/a | -11.54K | 38.85K | n/a | n/a |
Change in Working Capital | -212.97K | 152.87K | 143.41K | 267.61K | -170.8K | 438.37K | 179.62K | -2.36M | 562.85K | 1.58M | -151.1K | -778.09K | -439.43K | -385.2K | 551.78K | 586.24K | -595.15K | 932.16K | 506.22K | -2.48M | 280.54K |
Operating Cash Flow | -765.84K | -608.4K | -533.2K | -419.84K | -598.71K | -23.56K | -398.58K | -2.76M | -2.19M | -623.02K | -2.25M | -2.76M | -2.36M | -3.07M | -2.69M | -5.83M | -4.84M | -2.94M | -2.54M | -6.45M | -2.77M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -1.27K | n/a | n/a | -1.21K | -678 | -2.49K | -2.47K | -1 | -580 | n/a | n/a | -24.49K | -1.67K | -2.23K | -3.16K |
Cash Acquisitions | n/a | -3.41K | 60.07K | n/a | n/a | -15.91K | -4.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -2.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8 | 3.56K | n/a | n/a | 87 | 1.15K | n/a | n/a |
Other Investing Acitivies | n/a | -3.2K | n/a | n/a | n/a | n/a | n/a | 4.67M | n/a | n/a | n/a | n/a | n/a | n/a | 3.56K | n/a | n/a | 87 | 1.15K | n/a | n/a |
Investing Cash Flow | n/a | -9.05K | 60.07K | n/a | n/a | -15.91K | -5.84K | 4.67M | n/a | -1.21K | -678 | -2.49K | -2.47K | -9 | 2.98K | n/a | n/a | -24.4K | -521 | -2.23K | -3.16K |
Debt Repayment | -1.55K | -1.86K | -1.84K | -1.82K | -1.79K | -1.77K | -2.18K | -3K | -66.74K | -69.05K | -72.13K | -26.6K | -114.02K | -66.97K | -70.13K | -75.92K | -75.06K | -73.9K | -78.68K | -79.44K | -77.59K |
Common Stock Repurchased | -3.18K | n/a | -2.75K | -25.9K | n/a | n/a | n/a | n/a | -4.55K | n/a | -18.34K | -15.23K | n/a | n/a | n/a | -5.03K | -8.56K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.35K | 28 | -596 | -640 | -548 | -204.39K | 1.68K | 182.38K | 235.83K | -1.18M | -116.84K | 4.53M | -35.38K | -102.01K | 3.03M | -102.89K | -660.73K | 4.49M | -11.9K | -404.86K | -1.32M |
Financial Cash Flow | 65.43K | 82.66K | 361.01K | 649.19K | 97.99K | -1.72K | -494 | -57.41K | 164.55K | -58.35K | -188.96K | 4.48M | 1.03M | -168.9K | 4.19M | -170.25K | -744.35K | 8.16M | -90.18K | -455.96K | 8.79M |
Net Cash Flow | -703.46K | -539.86K | -113.79K | -524.49K | -516.25K | -7.44K | -438.6K | 2.16M | -2.24M | -888.63K | -2.41M | 1.57M | -1.36M | -3.47M | 1.61M | -6.07M | -5.6M | 5M | -2.62M | -7.11M | 6.53M |
Free Cash Flow | -765.84K | -608.4K | -533.2K | -419.84K | -598.71K | -23.56K | -399.86K | -2.76M | -2.19M | -624.23K | -2.25M | -2.76M | -2.36M | -3.07M | -2.69M | -5.83M | -4.84M | -2.97M | -2.54M | -6.45M | -2.77M |
Adj. Free Cash Flow | -788.75K | -608.4K | -533.2K | -419.84K | -623.62K | -23.56K | -438.31K | -2.8M | -2.58M | -1.01M | -2.74M | -3.25M | -2.79M | -3.76M | -3.59M | -6.49M | -6.28M | -3.24M | -2.92M | -6.79M | -2.96M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -1.27K | n/a | n/a | -1.21K | -678 | n/a | n/a | n/a | -580 | n/a | n/a | -24.49K | n/a | n/a | -3.16K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.49K | -2.47K | -1 | n/a | n/a | n/a | n/a | -1.67K | -2.23K | n/a |
Owner Earnings | -765.84K | -608.4K | -533.2K | -419.84K | -598.71K | -23.56K | -399.86K | -2.76M | -2.19M | -624.23K | -2.25M | -2.76M | -2.36M | -3.07M | -2.69M | -5.83M | -4.84M | -2.97M | -2.54M | -6.45M | -2.77M |
Add to Watchlist
Select watchlists to add or remove ADXN